3-Chloromethamphetamine

3-Chloromethamphetamine

3-Chloromethamphetamine

Substituted amphetamine derivative invented in the 1960s

3-Chloromethamphetamine (3-CMA, MCMA) is a substituted amphetamine derivative invented in the 1960s. In animal studies it was deemed to be a "hallucinogen" rather than a stimulant, though the assays used at the time did not distinguish between the compounds now termed psychedelics and those now termed empathogens.[1][2][3]

Quick Facts Clinical data, ATC code ...

See also

References

  1. [1]
    Knoll J, Vizi ES, Ecseri Z (February 1966). "Psychomimetic methylamphetamine derivatives". Archives Internationales de Pharmacodynamie et de Therapie. 159 (2): 442–51. PMID 5916746.
  2. [2]
    Brimblecombe RW, Pinder RM (1975). Hallucinogenic agents. Wright-Scientechnica. pp. 71–74. ISBN 978-0-85608-011-1.
  3. [3]
    Segawa H, T Iwata Y, Yamamuro T, Kuwayama K, Tsujikawa K, Kanamori T, Inoue H (March 2017). "Differentiation of ring-substituted regioisomers of amphetamine and methamphetamine by supercritical fluid chromatography". Drug Testing and Analysis. 9 (3): 389–398. doi:10.1002/dta.2040. PMID 27383263.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article 3-Chloromethamphetamine, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.